142 related articles for article (PubMed ID: 26788899)
41. Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers.
Cheng Y; Man N; Xu T; Fu R; Wang X; Wang X; Wen L
J Pharm Sci; 2007 Mar; 96(3):595-602. PubMed ID: 17094130
[TBL] [Abstract][Full Text] [Related]
42. Compounded Topical Amitriptyline for Neuropathic Pain: In Vitro Release from Compounding Bases and Potential Correlation with Clinical Efficacy.
Shakshuki A; Yeung P; Agu RU
Can J Hosp Pharm; 2020; 73(2):133-140. PubMed ID: 32362670
[TBL] [Abstract][Full Text] [Related]
43. Development and characterization of a ricinoleic acid poloxamer gel system for transdermal eyelid delivery.
Boddu SH; Bonam SP; Jung R
Drug Dev Ind Pharm; 2015 Apr; 41(4):605-12. PubMed ID: 24517574
[TBL] [Abstract][Full Text] [Related]
44. Comparison of the efficacy and skin permeability of topical NSAID preparations used in Europe.
Komatsu T; Sakurada T
Eur J Pharm Sci; 2012 Dec; 47(5):890-5. PubMed ID: 22985876
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of percutaneous permeation of flurbiprofen and ketoprofen after application of transdermal patches using a lateral sectioning approach in hairless rats.
Goi N; Morishita K; Taniguchi A; Ishii T; Saitoh K
Pharm Dev Technol; 2010 Dec; 15(6):658-65. PubMed ID: 20883157
[TBL] [Abstract][Full Text] [Related]
46. Functional characterisation of novel analgesic product based on self-regulating drug carriers.
Cevc G; Vierl U; Mazgareanu S
Int J Pharm; 2008 Aug; 360(1-2):18-28. PubMed ID: 18524509
[TBL] [Abstract][Full Text] [Related]
47. Effect of permeation enhancers on the release of ketoprofen through transdermal drug delivery systems.
Singh SK; Durrani MJ; Reddy IK; Khan MA
Pharmazie; 1996 Oct; 51(10):741-4. PubMed ID: 8941942
[TBL] [Abstract][Full Text] [Related]
48. [Percutaneous penetration of ketoprofen and ketoprofen isopropyl ester through a tissue engineering skin reconstructed with HaCaT cells].
Xu YF; Hu JH; Zhu QG; Xu S; Pan YH
Yao Xue Xue Bao; 2005 Sep; 40(9):782-6. PubMed ID: 16342676
[TBL] [Abstract][Full Text] [Related]
49. Formulation development, in vitro and in vivo evaluation of microemulsion-based gel loaded with ketoprofen.
Nikumbh KV; Sevankar SG; Patil MP
Drug Deliv; 2015; 22(4):509-15. PubMed ID: 24266589
[TBL] [Abstract][Full Text] [Related]
50. Effect of phonophoresis on skin permeation of commercial anti-inflammatory gels: sodium diclofenac and ketoprofen.
Souza J; Meira A; Volpato NM; Mayorga P; Gottfried C
Ultrasound Med Biol; 2013 Sep; 39(9):1623-30. PubMed ID: 23820249
[TBL] [Abstract][Full Text] [Related]
51. Drug-free gel containing ultra-deformable phospholipid vesicles (TDT 064) as topical therapy for the treatment of pain associated with osteoarthritis: a review of clinical efficacy and safety.
Conaghan PG; Bijlsma JW; Kneer W; Wise E; Kvien TK; Rother M
Curr Med Res Opin; 2014 Apr; 30(4):599-611. PubMed ID: 24164189
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of Transdermal Drug Permeation as Modulated by Lipoderm and Pluronic Lecithin Organogel.
Zhang Q; Song Y; Page SW; Garg S
J Pharm Sci; 2018 Feb; 107(2):587-594. PubMed ID: 28935590
[TBL] [Abstract][Full Text] [Related]
53. Effect of various vehicles on ketoprofen permeation across artificial membranes and excised rat skin.
Valenta C; Kerner A
Pharmazie; 1996 Aug; 51(8):605-6. PubMed ID: 8794474
[No Abstract] [Full Text] [Related]
54. Occlusion effect on transcutaneous NSAID delivery from conventional and carrier-based formulations.
Cevc G; Mazgareanu S; Rother M; Vierl U
Int J Pharm; 2008 Jul; 359(1-2):190-7. PubMed ID: 18499370
[TBL] [Abstract][Full Text] [Related]
55. Comparative evaluation of polymeric and waxy microspheres for combined colon delivery of ascorbic acid and ketoprofen.
Maestrelli F; Zerrouk N; Cirri M; Mura P
Int J Pharm; 2015 May; 485(1-2):365-73. PubMed ID: 25746948
[TBL] [Abstract][Full Text] [Related]
56. In vivo pharmacokinetics of ketoprofen after patch application in the Mexican hairless pig.
Horie M; Sekiya I; Nakamura T; Tanaka H; Maekawa K; Nakanishi M; Muneta T; Kobayashi E
Biopharm Drug Dispos; 2009 May; 30(4):204-8. PubMed ID: 19434661
[TBL] [Abstract][Full Text] [Related]
57. Percutaneous absorption of ketoprofen. I. In vitro release and percutaneous absorption of ketoprofen from different ointment bases.
Gürol Z; Hekimoğlu S; Demirdamar R; Sumnu M
Pharm Acta Helv; 1996 Aug; 71(3):205-12. PubMed ID: 8818309
[TBL] [Abstract][Full Text] [Related]
58. Serious photocontact dermatitis induced by topical ketoprofen depends on the formulation.
Guy RH; Kuma H; Nakanishi M
Eur J Dermatol; 2014; 24(3):365-71. PubMed ID: 24721981
[TBL] [Abstract][Full Text] [Related]
59. [The application of Harpagophytum procumbens extract in anti-inflammatory preparations applied on skin produced on acrylic acid polymers base].
Piechota-Urbańska M; Kołodziejska J; Berner-Strzelczyk A
Polim Med; 2009; 39(3):9-15. PubMed ID: 19873929
[TBL] [Abstract][Full Text] [Related]
60. Photobinding of ketoprofen in vitro and ex vivo.
Moser J; Sarabia Z; Minter H; Lovell WW; van Henegouwen GM
J Photochem Photobiol B; 2000 Oct; 58(1):37-45. PubMed ID: 11195851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
